SUBSCRIBE
SUBSCRIBE

Tiburio Therapeutics

NEWS
Tiburio Therapeutics is now a part of Mallinckrodt Pharmaceuticals.
Business
Top Life Sciences Startups to Watch in 2020
BioSpace is proud to present its NextGen Bio “Class of 2020,” a list of up-and-coming life science companies in North America that launched no earlier than mid-2018.
January 3, 2020
 · 
13 min read
 · 
Mark Terry
IN THE PRESS
Drug Development
Tiburio Announces Publication of Preclinical TBR-760 Data in Non-Functioning Pituitary Adenoma in Journal of the Endocrine Society
May 11, 2020
 · 
3 min read
Business
Tiburio Therapeutics Inc. Appoints Nerissa Kreher, MD, Chief Medical Officer
March 12, 2019
 · 
3 min read
Business
Cydan Announces Formation of Tiburio Therapeutics Inc. to Develop Treatments for Rare Neuroendocrine Tumors and Endocrine Diseases
January 3, 2019
 · 
7 min read
AWARDS
  • NextGen Class of 2020
JOBS